Ho Hwang - HansBiomed Chief Executive Officer, Director
| 042520 Stock | KRW 13,230 10.00 0.08% |
CEO
Hwang Ho Chan is Chief Executive Officer and Director of HANS BIOMED CORPORATION. Hwang used to work for CHINHUNG INTERNATIONAL INC and a Japanbased company. Hwang holds a Bachelor degree in Electrical Engineering from Hongik University, Korea.
| Age | 56 |
| Phone | 82 2 466 2266 |
| Web | https://www.hansbiomed.com |
HansBiomed Management Efficiency
The company has return on total asset (ROA) of (0.0946) % which means that it has lost $0.0946 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 13.6473 %, meaning that it generated $13.6473 on every $100 dollars invested by stockholders. HansBiomed's management efficiency ratios could be used to measure how well HansBiomed manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | CEO Age | ||
| Jae Lee | Daishin Information Communicati | 44 | |
Management Performance
| Return On Equity | 13.65 | |||
| Return On Asset | -0.0946 |
HansBiomed Leadership Team
Elected by the shareholders, the HansBiomed's board of directors comprises two types of representatives: HansBiomed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HansBiomed. The board's role is to monitor HansBiomed's management team and ensure that shareholders' interests are well served. HansBiomed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HansBiomed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ho Hwang, Chief Executive Officer, Director | ||
| Hong Yim, Director | ||
| Guen Kim, Chief Officer | ||
| Seok Oh, Chief Financial Officer, Assistant Managing Director | ||
| Jin Kim, Director | ||
| Jun Park, Director | ||
| Geun Kim, Internal Auditor | ||
| Seong Jeon, Director | ||
| Won Gwon, Assistant Managing Director | ||
| SeokBae Oh, Chief Director | ||
| Yong Cho, Director | ||
| Tae Kim, Director | ||
| Gye Kang, Director | ||
| Seong Park, Director | ||
| WonGyun Kwon, MD Director |
HansBiomed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is HansBiomed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 13.65 | |||
| Return On Asset | -0.0946 | |||
| Profit Margin | (0.31) % | |||
| Operating Margin | (0.33) % | |||
| Current Valuation | 184.7 B | |||
| Shares Outstanding | 8.95 M | |||
| Shares Owned By Insiders | 27.69 % | |||
| Shares Owned By Institutions | 1.50 % | |||
| Price To Earning | 38.44 X | |||
| Price To Sales | 1.46 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards HansBiomed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, HansBiomed's short interest history, or implied volatility extrapolated from HansBiomed options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in HansBiomed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the HansBiomed information on this page should be used as a complementary analysis to other HansBiomed's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for HansBiomed Stock analysis
When running HansBiomed's price analysis, check to measure HansBiomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HansBiomed is operating at the current time. Most of HansBiomed's value examination focuses on studying past and present price action to predict the probability of HansBiomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HansBiomed's price. Additionally, you may evaluate how the addition of HansBiomed to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |